BORIC ACID ALCOHOLIC SOLUTION 2 %

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT BORIC ACID ALCOHOLIC SOLUTION 2%

Composition:

Active ingredient: boric acid;

1 ml of solution contains boric acid 0.02 g;

Excipient: ethanol 70%.

Pharmaceutical form. Topical solution, alcoholic 2%.

Main physicochemical properties: clear colorless liquid.

Pharmacotherapeutic group.
Antiseptics and disinfectants. ATC code D08AD.

Pharmacological properties.

Pharmacodynamics. The drug exerts an antiseptic effect. It coagulates proteins (including enzymes) of microbial cells, disrupts the permeability of the cell membrane, thereby inhibiting bacterial growth and development.

Pharmacokinetics. When applied externally, the drug is absorbed through damaged skin and wound surfaces; if accidentally ingested, it is absorbed through the mucous membrane of the gastrointestinal tract. Boric acid can accumulate in body tissues. It is slowly eliminated from the body.

Clinical characteristics.

Indications.

Pyoderma, weeping eczema, intertrigo, acute and chronic otitis media.

Contraindications.

Hypersensitivity to boric acid, impaired renal function, chronic mesotympanitis with normal or minimally altered mucosa, traumatic perforations of the tympanic membrane; pregnancy or breastfeeding period, application to mammary glands. Contraindicated for use in children (including newborns).

Interaction with other medicinal products and other forms of interaction.

Interaction is currently unknown.

When using any other medicinal products simultaneously, inform your physician.

Special precautions for use.

Do not apply the medicinal product to large areas of skin; do not use for cavity irrigation. Avoid contact of the drug with the eyes.

Use during pregnancy or breastfeeding.

The drug is contraindicated in women during pregnancy or breastfeeding.

Ability to influence reaction rate when driving or operating machinery.

Does not affect.

Method of Administration and Dosage

Apply externally.

For pyoderma, intertrigo, and eczema, treat affected skin areas with a wipe moistened with the medication 2–3 times daily.

For otitis, insert into the external auditory canal swabs moistened with the solution or instill 3–5 drops 2–3 times daily.

Children

The drug is contraindicated in children.

Overdose

In case of accidental ingestion, perform gastric lavage via a tube, administer saline laxatives and enterosorbents (activated charcoal) orally, and provide symptomatic therapy.

Symptoms of acute poisoning: nausea, vomiting, diarrhea, circulatory disturbances, central nervous system depression, hypothermia, shock, coma, and erythematous rash. In cases of severe poisoning, take measures to support vital functions, perform hemodialysis or peritoneal dialysis, and carry out blood transfusion therapy. With prolonged use of the drug on large skin surfaces, symptoms of chronic intoxication may develop: tissue edema, exhaustion, stomatitis, eczema, menstrual cycle disturbances in women, anemia, seizures, and alopecia. In such cases, discontinue the drug and administer symptomatic treatment.

Side effects.

The use of the drug may cause allergic reactions (skin redness, itching, urticaria, rash, swelling). In isolated cases – development of anaphylactic reactions, including shock, epithelial desquamation.

With prolonged use, as well as in patients with impaired kidney function, nausea, vomiting, diarrhea, headache, confusion, oliguria, and seizures may occur.

If any adverse events occur, it is necessary to consult a physician!

Shelf life. 3 years.

Storage conditions.

Store at a temperature not exceeding 25°C.

Keep out of reach of children.

Packaging.

10 ml in vials or 20 ml in dropper bottles (in cardboard packs or without packs).

Supply category. Over-the-counter.

Manufacturer/Applicant.

LLC "Ternopharm".

Manufacturer's address and location of business activity/Applicant's address.

46010, 4 Fabrychna St., Ternopil, Ukraine.

Tel./Fax: (0352) 521-444, www.ternopharm.com.ua